Bevacizumab o Ranibizumab, o La Leyenda de Robin Hood y el Rey Ricardo [PDF]
, 2007 Jordi Monés
openalex +1 more source
The intravitreal injection: Variations in regulations, cost and reimbursement in Europe [PDF]
, 2018 Zusammenfassung: HINTERGRUND: Grosse prospektive, randomisierte, kontrollierte klinische Studien haben für den intravitrealen Einsatz von Inhibitoren des vaskulären endothelialen Wachstumsfaktors (VEGF) klare Behandlungsvorgaben mit höchstem ...
Becker, M. +3 more
core
Therapeutics and Clinical Risk Management, 2012 Youxin Chen, Fei HanDepartment of Ophthalmology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaAbstract: Wet age-related macular degeneration (AMD) causes severe vision loss due
Chen Y, Han F
doaj
Kartika: Jurnal Ilmiah FarmasiAnti-vascular endothelial growth factor (VEGF) injeksi intravitreal dapat digunakan untuk terapi pasien dengan gangguan mata. Obat anti-VEGF yang digunakan di antaranya bevacizumab, ranibizumab, aflibercept, dan brolucizumab.
Nur Sidik Cahyono +1 more
doaj +1 more source
The Role of Ranibizumab in Age-related Macular Degeneration – Emerging Clinical Data [PDF]
, 2007 Anna Tarantini, Paolo Lanzetta
openalex +1 more source
Intravitreal ranibizumab (Lucentis®) for the treatment of myopic choroidal neovascularization [PDF]
, 2008 Lazaros Konstantinidis +4 more
openalex +1 more source
A Review of Ranibizumab for the Treatment of Diabetic Retinopathy
Ophthalmology and Therapy, 2017 Laser photocoagulation has been the standard treatment for diabetic macular edema (DME) and proliferative diabetic retinopathy (PDR) for several decades. The discovery of vascular endothelial growth factor (VEGF) and the subsequent determination of its critical role in the development DME and PDR has led to the development of VEGF inhibitory drugs ...
openaire +2 more sources
Antibody Engineering to Enhancement of Ranibizumab Binding Affinity for the Prevention and Treatment of Diabetic Retinopathy [PDF]
Iranian Journal of Diabetes and ObesityObjective: The VEGF function blockage effectively reduces the progression of diabetic retinopathy. Ranibizumab and bevacizumab are some anti-VEGF monoclonal antibodies (mAb).
Fateme Sefid +3 more
doaj
Ranibizumab: The clinician's guide to commencing, continuing, and discontinuing treatment [PDF]
, 2008 Winfried M. K. Amoaku
openalex +1 more source
Ranibizumab for Macular Edema Due to Retinal Vein Occlusions: Implication of VEGF as a Critical Stimulator [PDF]
, 2008 Peter A. Campochiaro +15 more
openalex +1 more source